Moderna said it’s planning to submit a request to the U.S. Food and Drug Administration to authorize a low-dose COVID-19 vaccine for children under 6 years old, part of a push to inoculate the 18 million American children under 5 who are not yet eligible for vaccination – the last group to await eligibility.